Long term evaluation of prognostic factors in BCNU, cyclophosphamide, prednisone (BCP) treatment of myeloma
Publication
, Journal Article
Cohen, HJ; Silberman, HR
Published in: Proceedings of the American Association for Cancer Research
January 1, 1977
Duke Scholars
Published In
Proceedings of the American Association for Cancer Research
Publication Date
January 1, 1977
Volume
Vol.18
Citation
APA
Chicago
ICMJE
MLA
NLM
Cohen, H. J., & Silberman, H. R. (1977). Long term evaluation of prognostic factors in BCNU, cyclophosphamide, prednisone (BCP) treatment of myeloma. Proceedings of the American Association for Cancer Research, Vol.18.
Cohen, H. J., and H. R. Silberman. “Long term evaluation of prognostic factors in BCNU, cyclophosphamide, prednisone (BCP) treatment of myeloma.” Proceedings of the American Association for Cancer Research Vol.18 (January 1, 1977).
Cohen HJ, Silberman HR. Long term evaluation of prognostic factors in BCNU, cyclophosphamide, prednisone (BCP) treatment of myeloma. Proceedings of the American Association for Cancer Research. 1977 Jan 1;Vol.18.
Cohen, H. J., and H. R. Silberman. “Long term evaluation of prognostic factors in BCNU, cyclophosphamide, prednisone (BCP) treatment of myeloma.” Proceedings of the American Association for Cancer Research, vol. Vol.18, Jan. 1977.
Cohen HJ, Silberman HR. Long term evaluation of prognostic factors in BCNU, cyclophosphamide, prednisone (BCP) treatment of myeloma. Proceedings of the American Association for Cancer Research. 1977 Jan 1;Vol.18.
Published In
Proceedings of the American Association for Cancer Research
Publication Date
January 1, 1977
Volume
Vol.18